Jun 15, 2020
Therapeutic Solutions International Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune(TM) in Animal Studies
Jun 15, 2020
Elgia Therapeutics Announces New Funding to Develop Novel Treatments for Chronic Inflammatory and Fibrotic Diseases
May 18, 2020
NellOne Therapeutics files COVID-19 treatment patent
May 05, 2020
Therapeutic Solutions International Leverages Filed and Issued Intellectual Property to Develop COVID-19 Nutraceutical Candidate: QuadraMune(TM)
Apr 01, 2020
Salimetrics' Growing List of Cytokines Which Can Be Reliably Tested in Saliva Now Includes IL-17A, IL-5, and IL-7 for Fast, Easy Salivary Biomarker Analysis
Mar 27, 2020
6 Keys to Boosting Your Immune System During COVID-19
Mar 17, 2020
Cellenkos Inc. Focuses on the Development of Cell-Therapy for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS)
Jan 27, 2020
Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases
Jan 22, 2020
Okayama University Research: Herbal Medicines Can Treat Stomach Disorders
Jan 20, 2020
ZyVersa Therapeutics Releases Video Demonstrating How Inflammasomes Stimulate and Perpetuate Inflammation, and How a Novel Inflammasome Inhibitor, IC 100, Has Potential to Control Chronic Damaging Inflammation Associated with Inflammatory Diseases
Jan 08, 2020
Therapeutic Solutions International Reports Inhibition of Microglial Activation with NeuroStilbene
Dec 23, 2019
A Unique Nanopipette for the Level of Acidity of a Living Cell Measuring Will Help to Determine the Mechanism of Inflammatory and Oncological Processes
Nov 14, 2019
Corvidia Therapeutics to Present New Data at the American Heart Association's Scientific Sessions 2019
Nov 14, 2019
Viscos, LLC Announces Issuance of U.S. Patent for Hyaluronan Composition Use for Mitigation and/or Prevention of Inflammation and/or Pain
Sep 19, 2019
ZyVersa Therapeutics Unveils a White Paper Fostering Education About Inflammasomes and Their Potential as a Promising Therapeutic and Diagnostic Target for Inflammatory Diseases
Sep 12, 2019
ZyVersa Therapeutics' Perspectives on Inflammasomes Reported in BIOCENTURY Innovations Article
Sep 05, 2019
ZyVersa Therapeutics Advances Development of Lead Inflammasome Inhibitor Candidate, IC 100
Aug 01, 2019
Immunic AG Awarded Research Grant by German Federal Ministry of Education and Research in Support of the InnoMuNiCH Project
Jul 26, 2019
Th17 Inflammatory Pathway Therapeutics Markets, 2022
May 27, 2019
Trivedi Global, Inc. in Association with Sakina Ansari-Wilson Announces Research Results Impact of Biofield Energy Treated Nutraceutical to Reduce Inflammation Disorders